Purdue Pharma Names Senior VP of R&D

From DCAT Value Chain Insights (VCI)

By People On The Move posted 12-01-2015 11:50


Purdue Pharma L.P. has appointed Alan W. Dunton, MD, as senior vice president of research & development, reporting to Purdue's chief executive officer, Mark Timney. In this role, Dr. Dunton will serve as the company’s lead scientist and will oversee the Medical Research, Drug Safety, Clinical Pharmacology, Virtual Discovery, Project Management and Pharmaceutics & Analytics teams. He will be responsible for spearheading the company’s overall scientific development strategy, including management of the pipeline, early clinical development programs, and setting the scientific direction for the company.

Dr. Dunton has 33 years of experience in the discovery and development of new prescription and over-the-counter (OTC) drug products. In 2006, he founded Danerius LLC, a biotechnology and pharmaceutical consulting business, which he led until joining Purdue. Prior to starting Danerius, Dr. Dunton held executive-level positions in the pharmaceutical and biotechnology industries, including president and CEO of Panacos Pharmaceuticals and Metaphore Pharmaceuticals. He was also the president and managing director of the Janssen Research Foundation, the R&D arm of the pharmaceuticals division at Johnson & Johnson. During his career, Dr. Dunton has been responsible for the approval of more than 20 prescription and OTC products.

Source: Purdue Pharma


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription